Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Iotas, a US-based smart apartment platform backed by the Oregon State University-linked VC firm Rogue Venture Partners, yesterday completed an $8.5m series A round led by Telus Ventures, the corporate venturing arm of telecoms firm Telus, with participation from telecoms provider Liberty Global and chipmaker Intel’s corporate venturing division Intel Capital. Iotas has now raised more than $17m in total funding, it said. Intel Capital previously invested in 2017 adding to earlier funding from Rogue Venture Partners, National Science Foundation, Creative Ventures, Oregon Best, Portland Seed Fund and Oregon Angel Fund. Shyftplan, a Germany-based workforce scheduling platform, has received approximately €5m ($5.5m) in equity financing from backers including UnternehmerTUM Venture Capital (UVC) Partners, the venture capital firm affiliated with TU Munich’s tech transfer arm UnternehmerTUM, Deutsche Startups reported on Monday. SEK Ventures, the investment vehicle of transport company FlixMobility’s co-founders, also took part in the round, as did VC firms Senovo and Kizoo, and government-backed fund Coparion. UVC Partners, Coparion and Kizoo were returning investors, though details could not be confirmed. Diamidex, a France-based microbe monitoring technology developer formed by regional tech transfer office Satt Sud-Est, yesterday received €2m ($2.2m) in funding from Rugby Angels, unnamed members of staff and professionals from the healthcare sector. The capital – along with a $440,000 loan from oil and gas giant Total’s Développement Régional fund and a $550,000 grant from public investment bank Bpifrance – will be used to accelerate the commercial rollout of a system to detect  Legionella pneumophila bacteria in water, which causes Legionnaire’s disease. The technology is being marketed under the C4Hydro brand, one of the three original companies that were merged earlier this year to form Diamidex – the other two being Click4Tag and C4Biocontrol.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).